BOULDER, CO / ACCESSWIRE / May 9, 2024 / Sonoma Pharmaceuticals (Formerly Known As Oculus Innovative Sciences, Inc.), Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced the launch of its MicrocynAH® animal health care products in the Menards® chain of home improvement stores in the United States..

BOULDER，CO/ACCESSWIRE/2024年5月9日/Sonoma Pharmaceuticals（原名Oculus Innovative Sciences，Inc.）（纳斯达克：SNOA）是一家全球医疗保健领导者，开发和生产基于专利技术的稳定次氯酸（HOCl）产品，用于广泛的应用，包括伤口，眼睛，口腔和鼻腔护理，皮肤病，足病和动物保健，今天宣布在美国Menards®家装连锁店推出其MicrocynAH®动物保健产品。。

Menards is a family-owned company started in 1958 and headquartered in Eau Claire, Wisconsin. It has more than 300 home improvement stores located in Illinois, Indiana, Iowa, Kansas, Kentucky, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, West Virginia, Wisconsin, and Wyoming.

Menards是一家家族企业，成立于1958年，总部位于威斯康星州奥克莱尔。它在伊利诺伊州、印第安纳州、爱荷华州、堪萨斯州、肯塔基州、密歇根州、明尼苏达州、密苏里州、内布拉斯加州、北达科他州、俄亥俄州、南达科他州、西弗吉尼亚州、威斯康星州和怀俄明州拥有300多家家装店。

Sonoma's MicrocynAH products are distributed in the U.S. and Canada through its partner, Compana Pet Brands..

Sonoma的MicrocynAH产品通过其合作伙伴Companya宠物品牌在美国和加拿大销售。。

MicrocynAH products available through Menards stores and online include: Wound & Skin Care Spray, Wound & Skin Care Hydrogel, Eye & Ear Wash, Anti-Itch Gel Spray with Dimethicone and Hot Spot Gel Spray with Dimethicone.

通过Menards商店和在线提供的MicrocynAH产品包括：伤口和皮肤护理喷雾剂、伤口和皮肤护理水凝胶、洗眼和洗耳液、含二甲硅油的止痒凝胶喷雾剂和含二甲硅油的热点凝胶喷雾剂。

'We are excited to see the increased availability of our animal health care products into Menards stores,' said Amy Trombly, CEO of Sonoma Pharmaceuticals. 'Our Microcyn technology is safe and effective for any species, including dogs, cats, birds, reptiles and other animals, and with this expansion more pet owners will be able to find relief for their pets' common ailments.'.

Sonoma Pharmaceuticals首席执行官艾米·特罗姆布莱（AmyTrombly）说，我们很高兴看到我们的动物保健产品越来越多地进入Menards商店我们的Microcyn技术对任何物种都是安全有效的，包括狗、猫、鸟、爬行动物和其他动物，随着规模的扩大，更多的宠物主人将能够缓解宠物的常见疾病。

About Sonoma Pharmaceuticals, Inc.

关于Sonoma Pharmaceuticals，Inc。

Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Sonoma's products are clinically proven to reduce itch, pain, scarring, and irritation safely and without damaging healthy tissue.

Sonoma Pharmaceuticals是开发和生产稳定次氯酸（HOCl）产品的全球医疗保健领导者，产品应用广泛，包括伤口，眼睛，口腔和鼻腔护理，皮肤病，足病，动物保健和无毒消毒剂。Sonoma的产品在临床上被证明可以安全地减少瘙痒、疼痛、疤痕和刺激，并且不会损害健康组织。

In-vitro and clinical studies of HOCl show it to safely manage skin abrasions, lacerations, minor irritations, cuts, and intact skin. Sonoma's products are sold either directly or via partners in 55 countries worldwide and the company actively seeks new distribution partners. The company's principal office is in Boulder, Colorado, with manufacturing operations in Guadalajara, Mexico.

HOCl的体外和临床研究表明，它可以安全地处理皮肤擦伤，撕裂伤，轻微刺激，伤口和完整的皮肤。索诺玛的产品直接或通过全球55个国家的合作伙伴销售，该公司积极寻求新的分销合作伙伴。该公司的总部位于科罗拉多州的博尔德，制造业务位于墨西哥的瓜达拉哈拉。

European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at www.sonomapharma.com. For partnership opportunities, please contact busdev@sonomapharma.com..

欧洲营销和销售总部位于荷兰罗尔蒙德。有关更多信息，请访问www.sonomappharma.com。有关合作机会，请联系busdev@sonomapharma.com..

About Compana Pet Brands

关于Companya宠物品牌

With roots dating back to 1842, Compana Pet Brands is a global leader in pet care and nutrition dedicated to enriching the lives of pets and their families. Based in St. Louis and employing approximately 700 passionate pet lovers around the world, the company manufactures and markets more than 20 household brands in dog and cat, backyard chicken, equine, small animal and indoor bird categories.

Companya宠物品牌成立于1842年，是宠物护理和营养领域的全球领导者，致力于丰富宠物及其家人的生活。该公司总部位于圣路易斯，在世界各地雇佣了大约700名热情的宠物爱好者，生产和销售20多个家庭品牌，涉及狗和猫、后院鸡、马、小动物和室内鸟类。

Compana believes pets are an important part of the family and its broad portfolio of brands focuses on care and wellness solutions to improve the quality of life for pets of all shapes and sizes throughout their lifespans. For more information, visit companapetbrands.com or follow Compana on LinkedIn..

Companya认为宠物是家庭的重要组成部分，其广泛的品牌组合专注于护理和健康解决方案，以提高各种形状和大小的宠物在其一生中的生活质量。有关更多信息，请访问companypetbrands.com或在LinkedIn上关注Compana。。

Forward-Looking Statements

前瞻性声明

Except for historical information herein, matters set forth in this press release are forward-looking within the meaning of the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995, including statements about the commercial and technology progress and future financial performance of Sonoma Pharmaceuticals, Inc.

除历史信息外，本新闻稿中所述事项在1995年《私人证券诉讼改革法案》的“安全港”规定范围内具有前瞻性，包括关于Sonoma Pharmaceuticals，Inc.商业和技术进步以及未来财务表现的声明。

and its subsidiaries (the 'company'). These forward-looking statements are identified by the use of words such as 'continue,' 'develop,' 'anticipate,' 'expect' and 'expand,' among others. Forward-looking statements in this press release are subject to certain risks and uncertainties inherent in the company's business that could cause actual results to vary, including such risks that regulatory clinical and guideline developments may change, scientific data may not be sufficient to meet regulatory standards or receipt of required regulatory clearances or approvals, clinical results may not be replicated in actual patient settings, protection offered by the company's patents and patent applications may be challenged, invalidated or circumvented by its competitors, the available market for the company's products will not be as large as expected, the company's products will not be able to penetrate one or more targeted markets, revenues will not be sufficient to meet the company's cash needs, fund further development, as well as uncertainties relative to the COVID-19 pandemic and economic development, varying product formulations and a multitude of diverse regulatory and marketing requirements in different countries and municipalities, and other risks detailed from time to time in the company's filings with the Securities and Exchange Commission.

及其子公司（“公司”）。这些前瞻性陈述通过使用诸如“继续”、“发展”、“预期”、“期望”和“扩展”等词语来识别。本新闻稿中的前瞻性陈述受到公司业务固有的某些风险和不确定性的影响，这些风险和不确定性可能会导致实际结果发生变化，包括监管临床和指南的发展可能会发生变化，科学数据可能不足以满足监管标准或收到所需的监管许可或批准，临床结果可能无法在实际患者环境中复制，公司专利和专利申请提供的保护可能会受到竞争对手的质疑，无效或规避，公司产品的可用市场将不会像预期的那样大，公司产品将无法渗透一个或多个目标市场，收入将不足以满足公司的现金需求，为进一步发展提供资金，以及与新型冠状病毒大流行和经济发展相关的不确定性，不同国家和城市的不同产品配方和多种不同的监管和营销要求，以及公司向证券交易委员会提交的文件中不时详述的其他风险。

The company disclaims any obligation to update these forward-looking statements, except as req.

公司不承担更新这些前瞻性声明的任何义务，除非有要求。

Sonoma Pharmaceuticals™, Microcyn® and MicrocynAH® are trademarks or registered trademarks of Sonoma Pharmaceuticals, Inc. All other trademarks and service marks are the property of their respective owners.

Sonoma Pharmaceuticals™、Microcyn®和MicrocynAH®是Sonoma Pharmaceuticals，Inc.的商标或注册商标。所有其他商标和服务商标均为其各自所有者的财产。

SOURCE: Sonoma Pharmaceuticals, Inc.

资料来源：Sonoma Pharmaceuticals，Inc。

View the original press release on accesswire.com

在accesswire.com上查看原始新闻稿